Literature DB >> 16920573

Common variable immune deficiency and autoimmunity.

Daniel Brandt1, M Eric Gershwin.   

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous syndrome characterized by various degrees of hypogammaglobulinemia. Similar to many immunodeficiency disorders, autoimmunity is common with an association with autoimmune cytopenias, a sarcoidosis-like disorder and inflammatory bowel disease. Recent efforts have characterized selective immunological defects and genetic associations in CVID and demonstrate an increased tendency towards loss of tolerance. The mainstay of treatment of autoimmune disease in such patients is often high dose IVIG and corticosteroids, although other therapies, including TNF-alpha antagonists, have been reported. While the etiology of increased autoimmunity in CVID remains elusive, certain genetic predispositions in combination with repeated antigen exposure and overall immune dysregulation inherent in CVID likely play a significant role.

Entities:  

Mesh:

Year:  2006        PMID: 16920573     DOI: 10.1016/j.autrev.2006.03.010

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  37 in total

1.  Good's syndrome, CVID, and selective antibody deficiency in patients with chronic rhinosinusitis.

Authors:  Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

2.  Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma.

Authors:  M Kajii; C Suzuki; J Kashihara; F Kobayashi; Y Kubo; H Miyamoto; T Yuuki; T Yamamoto; T Nakae
Journal:  Clin Exp Immunol       Date:  2010-11-22       Impact factor: 4.330

3.  Dermal immunopathology: from genetics to effector mechanisms.

Authors:  Akira Takashima; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

4.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

5.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

6.  Overall reduction in antibody production could contribute to generate pathogenic autoantibodies and autoimmune manifestations.

Authors:  Ricardo García-Muñoz
Journal:  Clin Rheumatol       Date:  2008-12-18       Impact factor: 2.980

7.  GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.

Authors:  B J B Lewis; D Leontyev; A Neschadim; M Blacquiere; D R Branch
Journal:  Clin Exp Immunol       Date:  2018-09       Impact factor: 4.330

8.  Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.

Authors:  Ian K Campbell; Sylvia Miescher; Donald R Branch; Patrick J Mott; Alan H Lazarus; Dongji Han; Eugene Maraskovsky; Adrian W Zuercher; Anton Neschadim; Danila Leontyev; Brent S McKenzie; Fabian Käsermann
Journal:  J Immunol       Date:  2014-04-23       Impact factor: 5.422

Review 9.  Sarcoidosis presenting as "corset-like" myelopathy: a description of six cases and literature review.

Authors:  Merav Lidar; Amir Dori; Yair Levy; Zvi Lidar; Joab Chapman; Pnina Langevitz
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

10.  Common variable immunodeficiency in horses is characterized by B cell depletion in primary and secondary lymphoid tissues.

Authors:  M Julia B F Flaminio; Rebecca L Tallmadge; Cristina O M Salles-Gomes; Mary Beth Matychak
Journal:  J Clin Immunol       Date:  2008-08-02       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.